Most material SEC filings — July 6, 2026

Two Harbors Investment Corp. (NYSE: TWO) stockholders approved the merger with CrossCountry Mortgage, LLC on July 2, 2026. Common stockholders will receive $12.00 per share in cash plus a pro-rated stub dividend; preferred shareholders will be redeemed at $25.00 per share plus accrued dividends. The transaction has cleared HSR antitrust review and received 48 of 53 required state regulatory approvals, with expected closing in August 2026.

BioXcel Therapeutics (market cap ~$11M) executed its tenth amendment to its credit facility with Oaktree Capital and Q Boost Holding LLC (Qatar Investment Authority) on July 3, 2026. Key changes: deferred $9,016,914 payment due June 30 to July 31; reduced minimum liquidity requirement from $12.5M to $7.5M post-amendment; capitalized accrued interest and added 100 bps amendment fee (1% of outstanding principal) to loan balance; required board-approved Strategic Process Committee (independent director David Mack) with exclusive authority over sale, restructuring, bankruptcy, or equity raise; imposed strict operational controls including bi-weekly 13-week cash flow reporting, 15% variance cap on disbursements, ban on dividends/asset sales/IP transfers/compensation increases through July 31, weekly lender meetings, and requirement to enter definitive agreements for acceptable transaction by July 31 or face default; removed all transfer restrictions on lenders' loan interests.

Invivyd received FDA Notice of Termination for PEMGARDA's COVID-19 Emergency Use Authorization, effective June 29, 2027, following HHS termination of the COVID-19 EUA declaration. The company has a 12-month transition period and is in dialogue with FDA on next steps, stating it believes PEMGARDA has sufficient clinical data to support a full Biologics License Application (BLA) submission and approval. PEMGARDA, approved under EUA in March 2024 for pre-exposure prophylaxis in immunocompromised patients, is Invivyd's primary commercial product.

On July 2, 2026, Jet.AI stockholders voted 99% in favor (768,718 of 778,325 shares cast) to approve a merger with flyExclusive, Inc. The deal involves a spinoff of Jet.AI SpinCo, Inc., with existing Jet.AI shareholders retaining their shares and receiving merger consideration. The transaction is expected to close July 7, 2026, allowing Jet.AI to focus on AI infrastructure while flyExclusive expands its private aviation platform.

As of June 28, 2026, Bitmine holds 5,742,237 ETH valued at $10.3B (at $1,800/ETH), plus $527M cash/securities and other crypto, totaling $11.1B. The company closed a $273.8M net proceeds offering of 3.5M shares of Series A Preferred Stock at $80/share on June 10, 2026, now trading on NYSE under BMNP with weekly dividends at 9.50%. Bitmine was added to the Russell 1000 index on June 26, 2026, and operates 4.88M staked ETH generating annualized revenues of $235M ($277M projected at full staking).

Trafalgar Asset Management, LLC agreed to acquire all 7,628,665 Series A Preferred shares from six sellers (Aitan Zacharin, 02490585 Ontario Inc., Yonah Kalfa, Rakefet LLC, Fernando Bisker, Sigalush Ventures LLC) and all 1,000 Series B Preferred shares from Aitan Zacharin (dated June 29, 2026). The purchase price is blank/undisclosed in the filing. Simultaneously, GCAN will cancel $180,000 and $80,000 convertible notes to the same parties. Porfirio Sanchez Talavera replaces Zacharin as sole CEO and director. Trafalgar gains complete voting control and operational management of the OTC-quoted public company.

Polar Power, Inc. (market cap ~$3.0M) filed an 8-K on 2026-07-06 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The filing does not disclose the specific listing standard violated, the exchange involved, timeline for remediation, or any management response in the accessible text provided.

Cytosorbents Corp filed an 8-K on July 6, 2026 reporting Item 3.01 — Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing. The filing does not disclose specific reasons, counterparties, dollar amounts, dates of non-compliance, or remediation timeline in the metadata provided. The core fact is a delisting notice; substantive details are absent from this extract.

Scilex (market cap ~$32.4M) signed a binding term sheet with iHolding Group LLP (Almaty, Kazakhstan) for a $100M strategic investment at $15/share, representing ~6.67M shares. The investment is contingent on due diligence completion, definitive agreement execution, board/stockholder/regulatory approvals, and would fund product development, acquisitions, working capital, and general corporate purposes. This represents a transformational capital infusion approximately 3× the company's current market capitalization.

Envirotech Vehicles, Inc. (public market cap ~$6.4M) merges with Azio AI Corporation (private) in a two-step transaction dated July 2, 2026. Azio AI shareholders receive 2,655,157 shares of Envirotech common stock (capped at 19.9% pre-transaction outstanding) plus 973,450 shares of convertible preferred stock (convertible 1:1000 into common, subject to shareholder vote). Two convertible notes of Azio AI ($150K aggregate principal) convert to Parent common stock. Post-closing, Envirotech's name changes to Azio AI Holdings, Inc.

Public Company Management Corp (PCMC, ~$7.2M market cap) is acquiring all issued shares of Physicians Capital Management Corporation from Dr. Conrad Ivie and employee stockholders. PCMC will issue 68.6M common shares and 24.9M preferred shares (93.5M total) representing ~80% fully-diluted ownership post-closing. Dr. Ivie receives 1M Series A voting shares (15 votes each), 15.9M Series B-1 convertibles (4:1 conversion ratio at 18 months), and 7.9M Series B-2 convertibles (8:1 conversion ratio at 24 months), ensuring him ≥51% voting control. Employee stockholders receive only common shares, carved from Ivie's allocation. PCMC will also issue 3.75M Series B-1 shares to Specialty Capital Lenders LLC to cancel outstanding notes. Registration on Form S-4 required; closing conditioned on SEC effectiveness.

ClearOne Inc. (CLRO, $5.1M market cap) is acquiring all outstanding equity of Cortigent, Inc. from Vivani Medical, Inc. (Seller) via merger. Consideration: 12,500,000 shares of Parent Common Stock to Seller, subject to lock-up (50% for 1 year, 50% for 2 years). Parent also plans concurrent financing of $10–15M gross proceeds (2.5M–5M units, each unit = 1 share + 1 warrant exercisable at $10/share for 6 months). Agreement dated July 1, 2026; closing contingent on stockholder approvals, registration effectiveness, Nasdaq listing, and financing completion.

Director VisionWave Holdings, Inc. (SVRE) bought 16934.7M shares (~$116.2B) on the open market (41% of holdings). Open-market insider purchase — historically a bullish signal.

TeraWulf executed a 20-year lease with Anthropic for its Justified Data campus in Kentucky, generating ~$19 billion in contracted revenue over the initial term with 401 MW capacity coming online in H2 2027. Simultaneously, TeraWulf sold its 50.1% ownership stake in the Abernathy Joint Venture to Fluidstack-led investor group, monetizing its ~$450 million investment 'at a premium' and recycling capital into wholly owned infrastructure. The Abernathy project (168 MW in Texas, established 2025) will remain under Fluidstack's operational control post-closing.

Middleby Corporation and newly formed Midera Food Processing, Inc. entered into a Separation and Distribution Agreement dated July 5, 2026, to separate Middleby's Food Processing Equipment Group operating segment into an independent public company. RemainCo will distribute all Midera shares pro-rata to Middleby shareholders at a 1:1 ratio (one Midera share per Middleby share). The transaction includes transfer of specified assets/liabilities to Midera, with Midera obtaining debt financing (SpinCo Financing Arrangements) and RemainCo retaining all intercompany liabilities not expressly allocated to Midera.

On June 30, 2026, Big Digital Energy, Inc. (market cap ~$6.5M) issued 16,700 shares of Series D Convertible Preferred Stock at $900/share ($15.03M aggregate subscription amount; 90% of $1,000 stated value) to purchaser Six Thirty AI, LLC. Each preferred share converts to common stock at 95% of 5-day VWAP (floor price $1.80), accrues 5% annual dividends (18% post-triggering event), carries a 4.99% beneficial ownership cap, and includes warrants to purchase 926,748 common shares at $10.81/share (120% of closing price prior day). Issuance triggered certificate of designations establishing senior liquidation preferences, broad anti-dilution rights, and extensive covenants including $5M minimum stockholders' equity requirement.

iPower Inc. (market cap ~$9.8M) issued a $2.0M Series A Senior Secured Convertible Note to an institutional investor on July 6, 2026. The note carries a 10% annual interest rate, converts at $2.39/share, matures July 6, 2028, and is secured by company collateral. An amendment to the underlying Securities Purchase Agreement increased total facility size from $28.2M to $30.2M and Series B notes from $21M to $23M; the investor received $5.184M in Series A notes and $1.816M in Series B notes in the initial close, with rights to $2M additional mandatory closing and up to $23M in optional closings. Proceeds are unrestricted for AI infrastructure, supply chain initiatives, and general corporate purposes.

CISO Global, Inc. received a notice of delisting or failure to satisfy continued listing rules as of June 30, 2026. The specific listing standard(s) violated and any cure periods are not detailed in the available filing text. No financial amounts, counterparties, or remediation timeline are disclosed in the header documents.

Splash Beverage Group (market cap ~$6.5M) executed an exclusive worldwide license agreement with Argent Biopharma Limited for CannEpil, a pharmaceutical-grade CBD/THC formulation for drug-resistant epilepsy, effective July 6, 2026. Key terms: SBEV pays 15% royalty on net revenue for 10 years or patent life; Mercer Street (Argent's creditor) forgave $5.52M in convertible notes in exchange for $5.5M in Series D preferred equity issued by SBEV; C/M Capital committed minimum $1M investment in SBEV. SBEV gains exclusive development, manufacturing, and commercialization rights in all territories; Argent manufactures the product initially but SBEV may engage alternative manufacturers under specified conditions.

Maison Solutions sold its 91.67% stake in Super HK of El Monte, Inc. to DNL Management Inc. (which already owned 8.33%) for $1 on July 2, 2026. The effective date for profit/loss allocation was backdated to April 30, 2026. Buyer assumes all company liabilities, including an SBA Economic Injury Disaster Loan (original principal $500,000) and an ATW pledge on the equity interest. Seller retains minimal recourse: indemnification capped at $1 with broad disclaimers.

AIS Engineering (Cemtrex subsidiary) acquired Plant Engineering Services, a Fort Wayne-based engineering firm, for ~$3.5M cash at closing plus up to $1.5M earnout over 3 years tied to gross profit thresholds. PES, founded 30+ years ago and led by Mark Bohler (continuing as President), provides hydraulic/mechanical press engineering and modernization services. Expected to contribute $4–5M revenue over next 12 months and be profitable immediately.

Zoomcar Holdings engaged ThinkEquity LLC as exclusive placement agent (dated June 30, 2026) to raise capital by issuing 195 Series A Units, each consisting of one share of Series A Convertible Preferred Stock (convertible at $0.05/share) plus one warrant. ThinkEquity receives 10% cash fee on aggregate proceeds, 1% expense allowance, and warrants equal to 10% of fully-diluted common shares issued. Concurrently, Zoomcar extended CEO Deepankar Tiwari's consultancy agreement by one year (to May 9, 2027).

MGT Capital converted a $1,220,240 secured convertible note from Project Nickel LLC (dated Sept 2025) into 3.25M Series E preferred shares and 750.131M common shares on June 30, 2026. Simultaneously, the company conducted a $50,000 private placement of common stock at $0.00033/share (150M shares) to accredited investors, with Jonathan Pfohl (Interim CEO/CFO) executing both agreements.

Solstice Advanced Materials (SOLS) announced a definitive agreement to acquire Element Solutions Inc. (ESI) for approximately $14.5 billion including net debt assumption. Element shareholders receive $10.00 cash plus 0.500 Solstice shares per share (~$50.10 total, 15% premium to July 2, 2026 close). Combined entity will have ~$6.8B FY2025 revenue, $1.7B adjusted EBITDA (26% margin including $180M run-rate synergies). Transaction expected to close H1 2027, funded via $4.7B Goldman Sachs bridge commitment, new debt, and cash. Element shareholders will own ~44% of combined company post-close.

SK hynix Inc., South Korea's second-largest DRAM manufacturer (29.1% market share Q1 2026) and HBM leader (56.4% share), filed Amendment No. 2 to Form F-1 on July 6, 2026 for a US public offering of 17.79 million common shares via ADSs at US$158.14/ADS (based on KRX KOSPI trading price W2,425,000 on July 3, 2026). Cornerstone investors indicated interest in up to US$7 billion. Estimated net proceeds ~US$28 billion will fund W45.5 trillion in Korean fab construction (Yongin Fab 1, PT7 packaging plant) and W11.9 trillion in EUV scanner acquisitions through end-2027. Q1 2026: revenue W52.6 trillion (+198% YoY), profit W40.3 trillion (+397% YoY).

U.S. GoldMining has started drilling at its 100%-owned Whistler Gold-Copper Project in Alaska. The company has activated one drill ahead of schedule and a second is en route to test 8-10 high-priority targets within the Whistler Orbit district cluster. The 2026 program is fully funded for a minimum of 6,000 meters of core drilling, with first assay results expected by Q3 2026; this follows a March 2026 PEA modeling a $2.0 billion NPV5% for the primary Whistler deposit alone.

On July 2, 2026, CoreCivic sold its California City Detention Facility (2,560 beds; $732.6M) and Otay Mesa Detention Center (1,994 beds; $739.2M) to the U.S. Department of Homeland Security for a combined $1.5B gross price. After taxes (~$400M) and transaction costs, CoreCivic expects net proceeds of ~$1.1B, which it plans to use to repay $477.8M in debt (revolving credit, term loans, and 4.75% senior notes due Oct 2027), with remainder available for general corporate purposes including potential share repurchases and growth investments. CoreCivic may continue managing both facilities under existing ICE contracts through August 2027 (California City) and December 2029 (Otay Mesa, with 5-year extension option).

Maison Solutions Inc. agreed to sell assets of two loss-generating Asian grocery stores (San Gabriel and Monrovia, CA locations) to Enson Market entities (buyers Qinghui Ni, CEO) for $4.5M total ($2.25M each location: $2.24M assets + $10K beer/wine licenses), with inventory purchased separately. Closing expected by December 31, 2026. Payment structure: lump sum due by December 31, 2026, or if SBA financing fails, seller-financed via promissory notes at 10% interest (18% on default), with security interest in collateral and personal/corporate guaranty from Qinghui Ni and Enson Group Inc. Sellers retain right to payoff prior SBA COVID loans.

Verde Renewables entered a Master Commercialization and Collaboration Agreement with Ergon Asphalt Emulsions (effective July 1, 2026) establishing Verde as preferred vendor of engineered biochar for Ergon's cold paving products and other applications. The deal includes an initial project with target supply volumes (redacted), 50/50 carbon credit split, and a per-gallon royalty (redacted) on Ergon's emulsion sales. The 10-year initial term may renew for 5 additional years; either party may terminate with 6 months' notice at initial term expiration or upon material breach (with cure periods) or leadership change affecting Verde's CEO/COO.

Jolie Kahn resigned as CEO effective immediately on July 6, 2026. The Board appointed Pete Wylie, serving as Chief Operating Officer, as Interim CEO while continuing his COO duties. The Board has retained ZRG Partners to conduct a comprehensive search for a permanent CEO successor. No disagreement with company operations cited for departure.

Volato Group eliminated all outstanding convertible notes in Q2 2026, exiting the quarter with ~$8.4M cash and total liabilities (excluding deferred revenue) down 75% YoY to ~$5M. Vaunt marketplace posted record Q2 cash sales of $2.2M (199% YoY growth), with ARR projected at $4.7M (250% YoY growth) and 2,743 paid members (71% YoY growth). Management is pursuing a potential strategic merger targeted for Q3 2026 in AI infrastructure/software sectors.

Capstone Holding Corp. and investor Tumim Stone Capital, LLC amended their June 16, 2026 stock purchase agreement effective July 2, 2026. The amendment modifies the valuation period end time from 4:00:02 p.m. to 3:59:59 p.m. and redefines VWAP Purchase Price calculation to equal the greater of (i) the lowest traded price during the valuation period or (ii) 90% of VWAP (excluding opening and closing prints), subject to minimum price thresholds. The amendment applies prospectively to VWAP purchase notices delivered after July 2, 2026.

On July 1, 2026, Neolara Corp. (total assets ~$15K) entered a non-binding letter of intent to potentially acquire a Hong Kong-based AI-driven photo restoration and image enhancement company for 100% of equity or substantially all assets. No purchase price, financing terms, or deal timeline were disclosed. The transaction is non-binding, subject to due diligence, definitive agreement negotiation, regulatory approval, and customary closing conditions with no assurance of completion.

Solstice Advanced Materials agreed to acquire Element Solutions Inc. in a cash-and-stock transaction valued at approximately $14.5 billion (including assumed net debt), announced July 6, 2026. Element shareholders receive $10.00 cash plus 0.500 Solstice shares per Element share (~$50.10/share, 15% premium to July 2 close). Combined FY2025 pro forma revenue ~$6.8B, adjusted EBITDA $1.7B (26% margin including $180M run-rate synergies). Transaction expected to close H1 2027 pending regulatory and shareholder approvals; Solstice funded by $4.7B Goldman Sachs bridge commitment plus new debt and cash on hand; expected net leverage 3.5x at close, delevering below 3x within 18 months.

Cosmos Health's Board authorized a share repurchase program of up to $5 million through December 31, 2026. The repurchase will occur in open market, private transactions, or other permitted means under SEC rules. CEO stated the program represents ~50% of the company's $9.5M market cap as of June 29, 2026, reflecting confidence in operating fundamentals and belief that shares are undervalued.

On July 29, 2024, Synergy Empire Limited (SHMY, Nevada-incorporated shell company with ~$2K assets) agreed to acquire 100% of Meluha Therapeutics Berhad (Malaysian biotech, ~$2.2K assets) by issuing 10,000,000 shares of Series A Preferred Stock at $0.2155/share ($2,155,000 aggregate). The acquisition closed March 28, 2025. Meluha shareholders (Ramesh A/L Saravanamuthu 33.6%, Abdul Jalil bin Jidon 31.9%) received preferred shares and will control 56.8% combined voting power post-close. This is a reverse recapitalization; Meluha is the accounting acquirer. Meluha manufactures cell-based therapeutics (myCell, Chondrogen) targeting osteoarthritis in Malaysia; FY2024 revenue $1.006M, net income $667K; 9M FY2025 revenue $1.253M, net income $194K. Going concern doubt noted due to $1.9M accumulated deficit and negative working capital.

Bespoke Extracts amended its December 2024 Senior Secured Promissory Note on June 30, 2026, extending maturity from June 30 to August 14, 2026 (45 days), raising interest from 15% to 17% p.a. for the extension period, and issuing common shares equal to 10% of outstanding principal (valued at 10-day VWAP ending June 30, 2026) within 30 days. The amendment binds all noteholders under Simple Majority consent provisions. Original principal amount and holder identity are not disclosed in the exhibit.

Edgemode signed a non-binding term sheet on 1-Jul-26 with Pure Data Centres Group Limited to sell data centre development land in Spain (Cordoba, Palma sites targeting 300MW capacity) for up to €97.5M base consideration plus overage payments if project yield exceeds 12.5%. Deal structure includes €1.5M upfront per site upon SPA execution, €1.5M upon Ready-to-Build status, and €325k per MW of IT capacity on completion. Pure funds 100% pre-development costs (~€5M per site). Edgemode granted optional 25% equity reinvestment into joint venture. 60-day exclusivity period commenced; deal conditional on securing permits, gas pipeline consent, and binding hyperscale customer contract within 36 months.

FOXO reported Q1 2026 net revenues of $5.1M (vs. $3.2M prior year) and reduced operating loss to $0.3M (vs. $1.5M prior year). The company effected a 1:3,000 reverse stock split and converted ~$7.8M in Series A Preferred Stock into non-convertible debt. CEO Seamus Lagan licensed the company's epigenetics IP to LongevityFP Technologies (owned by former CEO Jon Sabes) for a 3% royalty (capped at $1.3M) plus a 10-year option for majority ownership of FOXO Labs subsidiary, with FOXO retaining 40%. The company is exploring uplisting to NYSE American and considering acquisitions, including a potential $10M+ annual revenue deal in Vector BioSource's pharmaceutical biospecimen space.

Fathom Holdings amended its May 2024 sale of Dagley Insurance Agency to D6 Holdings (controlled by Nathan Dagley). The $3M deferred payment due May 2026 is now split into three installments ($985K already paid, $1M due July 1, 2026, $1.015M due September 1, 2026). In exchange, Dagley cancels 278,000 Fathom shares and releases all claims against Fathom; Fathom releases claims against Dagley. Service obligations are modified to condition future client referrals on service quality standards.

RxSight entered a non-exclusive collaboration with Alcon to develop adjustable presbyopia-correcting intraocular lenses (PCIOLs) combining RxSight's light-adjustable technology with Alcon's PCIOL optics. RxSight receives $60 million upfront, up to $140 million in additional milestone payments, royalties on net sales, and will handle development/manufacturing while Alcon leads global commercialization. Deal announced July 6, 2026.

Barnwell Industries amended its 2018 Equity Incentive Plan, increasing total authorized shares to 3,800,000 and establishing individual annual limits: 340,000 for incentive stock options, 340,000 for non-qualified options/SARs, 270,000 for restricted stock/RSUs, and 100,000 for other awards. Non-employee directors may receive shares equal to their fee value if greater. No prior plan share authorization amount is stated in the filing.

Rubico Inc. filed a Form F-1MEF on July 6, 2026, increasing registered common shares by 48,000,000 (post-reverse stock split effective June 26, 2026) under Rule 462(b). The additional shares are to be sold by B. Riley Principal Capital II, LLC pursuant to a Purchase Agreement dated April 20, 2026. No new filing fee was required as the maximum aggregate offering price remained unchanged from the initial F-1 registration (File No. 333-295199, effective May 1, 2026).

Roadzen Inc. reported Q4 FY2026 revenue of $16.1 million (42% YoY growth) and full-year FY2026 revenue of $55.0 million (24% YoY growth). Net loss fell 69% to $(22.5) million for the full year from $(72.9) million in FY2025, with Adjusted EBITDA loss improving 58% to $(3.5) million. The company achieved its seventh consecutive quarter of sequential Adjusted EBITDA improvement and completed two strategic acquisitions: EliteCover (U.S. commercial auto insurance) and VehicleCare (India claims and repair), with over $30 million in new annual revenue commitments secured in Q1 FY2027.

P3 Health Group, LLC amended its Repurchase Promissory Note with counterparty IHC Health Services, Inc., extending the maturity date from an unspecified earlier date to September 30, 2028, and increasing the accrued interest rate from 11% per annum to 14% per annum effective June 30, 2026. The amendment required consent from CRG Servicing LLC. Specific principal balance and prior maturity date are not disclosed in this filing.

Idaho Copper Corporation completed an underwritten public offering raising approximately $18,000,000 gross proceeds at $4.85 per share and warrant on July 6, 2026. ThinkEquity served as sole book-running manager. The underwriters received a 45-day over-allotment option for up to 556,800 additional shares/warrants and purchased 556,800 warrants. Proceeds will fund completion of an updated Preliminary Economic Assessment, first phase of Prefeasibility Study work, and general corporate purposes.

USBC, Inc. (formerly Know Labs, Inc.) filed Amendment No. 3 to its Form S-1 registration statement on July 6, 2026, covering the issuance and sale of 359,815,000 shares of common stock, par value $0.001 per share. The filing includes legal opinions from Holland & Hart LLP confirming the shares are duly authorized, validly issued, fully paid, and non-assessable, and consent from independent auditor BPM LLP to incorporate their March 24, 2026 audit report. No offering price, underwriter details, or use-of-proceeds information is disclosed in these exhibits.

Element Solutions Inc. (public company, ~$3.9B market cap) has agreed to be acquired by Solstice Advanced Materials Inc. in an all-stock and cash transaction. Each Element share converts to 0.5 Parent (Solstice) shares plus $10.00 cash. As of July 1, 2026 capitalization date, 243.7M Element shares are outstanding; 158.8M Parent shares outstanding. Deal signed July 6, 2026; closing expected within months subject to stockholder votes and regulatory approvals. Three Element board members will join Parent's 11-person board post-close. No termination fees or go-shop period specified in merger agreement excerpt.

Charles M. Gillman purchased 521,841 shares of TransAct Technologies common stock in open-market transactions between May 15 and July 1, 2026, at prices ranging from $3.50 to $5.80 per share, for a total investment of approximately $2.54 million. The largest single purchase was 150,000 shares on May 21, 2026 at $3.73/share. This accumulation represents a significant insider vote of confidence during a period of stock-price appreciation.

On April 21, 2026, Laird Superfood acquired all equity of Terrasoul Superfoods, LLC for $48.0M cash (subject to post-closing adjustments) plus contingent consideration up to $5.0M based on 2026 contribution margin milestones. At closing, Laird repaid Terrasoul's $9.1M in debt (revolving line of credit $5.55M, notes payable $2.45M, member loans $1.12M) and paid $2.88M to vested performance unit holders. Terrasoul generated $65.8M revenue (2025) with $3.7M net income and $4.5M members' equity as of Dec 31, 2025.